Vaccine News and Research

Latest Vaccine News and Research

Inverse relationship between mortality rates and performance in the hospital quality alliance measures

A new study from the Harvard School of Public Health (HSPH) shows that patients who go to hospitals ranked higher according to specific quality measures have a lower chance of dying than patients treated at lower-ranked hospitals.

17 Jul 2007

Myeloid-derived suppressor cells suppress anti-tumor response to cancer

Scientists at Johns Hopkins and elsewhere say they have mapped out an escape route that cancers use to evade the body's immune system, allowing the disease to spread unchecked.

17 Jul 2007

Children at birthday party paid by 'MMR row' doctor for their blood

The General Medical Council (GMC) in Britain has heard that Dr. Andrew Wakefield, who is facing allegations of serious professional misconduct with regard to research on the triple measles-mumps-rubella MMR vaccine, paid children £5 to take their blood samples at his son's birthday party.

16 Jul 2007

Experts in Britain wholeheartedly back MMR jab

A disciplinary hearing due to begin this week in the UK may well settle the debate over any link between the measles, mumps and rubella vaccine (MMR) and autism.

16 Jul 2007

Paint helps surgeons see where a tumor begins and ends

A tumor paint developed by researchers at Seattle Children's Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.

16 Jul 2007

Do vaccines promote a false sense of security?

A new study examines whether a vaccine that offers only partial protection can backfire by increasing risky behavior, as a false sense of security could make recipients less careful than they otherwise would be.

16 Jul 2007

Bavarian Nordic granted new European patent on modified vaccinia virus Ankara

The European Patent Organisation (EPO) has granted a patent to Bavarian Nordic which further strengthens its intellectual property position on MVA in Europe.

12 Jul 2007

Novavax licenses virus-like particle from Wyeth

Novavax, Inc. has announced that is has signed a non-exclusive, worldwide license agreement with Wyeth, to obtain rights to a patent application covering virus-like particle (VLP) technology for use in human vaccines in certain fields of use.

10 Jul 2007

Women's HIV/AIDS conference delegates develop action plan to foster women's, girls' leadership in fight against disease

Delegates on Saturday at the close of the first International Women's Summit on Women's Leadership and HIV and AIDS in Nairobi, Kenya, released a 10-point action plan that aims to foster leadership roles of women and girls in the fight against HIV/AIDS, the Nation/AllAfrica.com reports.

10 Jul 2007

How the HIV virus mutates to escape the body's immune system

A pioneering collaborative study has discovered how the HIV virus evades the human body's immune system.

9 Jul 2007

Researchers discover why some mosquitoes are resistant to malaria

A team led by UT Southwestern Medical Center researchers has discovered why some mosquitoes are resistant to malaria, a finding that may one day help fight a disease that afflicts and kills millions of people.

9 Jul 2007

Link between autism and triple vaccination questioned again

According to a new but as yet unpublished study, the number of children in Britain with autism is far higher than previously thought.

8 Jul 2007

Bioethics training helps fight African brain drain

When African professionals migrate to the United States or Europe, it's often called brain drain.

4 Jul 2007

Harnessing the power of the immune system to fight cancer

Teaching a body's own immune system to seek out and destroy cancerous tumours represents a promising way to fight a disease that kills more than 70,000 Canadians a year.

4 Jul 2007

Are we looking at cancer vaccine trials the wrong way?

Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment.

4 Jul 2007

Discovery of two effective antibodies for SARS

An international team of investigators has identified the first human antibodies that can neutralize different strains of the virus responsible for outbreaks of severe acute respiratory syndrome (SARS).

4 Jul 2007

The next era of cancer treatment

Teaching a body's own immune system to seek out and destroy cancerous tumours represents a promising way to fight a disease that kills more than 70,000 Canadians a year.

4 Jul 2007

Rethinking therapeutic cancer vaccine trials

3 Jul 2007

Prevention and control of zoonoses

Over 180 international scientific experts will meet for the next three days near Lucca, Italy, to discuss state-of-the-art advances in infectious diseases transmitted from animals to man, known as zoonoses.

29 Jun 2007

Cervarix vaccine provides broad protection against cervical cancer

Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.

29 Jun 2007